Icon Group and Evidia announce strategic partnership to advance cancer care in Germany

Advancing oncology through innovation

Together, Evidia and Icon will leverage cutting-edge technologies to enhance access to world-leading radiotherapy across Germany.  

The partnership will enable acceleration of more targeted, and technologically advanced treatment options, ensuring that patients benefit from the latest in cancer care. 

A shared vision  

Cancer rates are rising globally, with Germany and Australia expected to see a 50% increase over the next two decades. Meeting this challenge requires innovative, patient-centred solutions.  

Evidia, the leading provider of diagnostic imaging services in Germany, Norway, Sweden, and the UK, and Icon, a leading provider of integrated cancer care with a global footprint, are joining forces to set new benchmarks in oncology care. 

Combining expertise for better patient outcomes

Both organisations share a commitment to medical excellence, technological innovation, and patient-centred, timely care.  

Evidia: Renowned for radiological precision, high-tech equipment, AI-driven solutions and its nationwide network of more than 95 radiology practices and four radiotherapy centres, Evidia is dedicated to delivering uncompromising care quality and improving patient outcomes across Germany. 

Icon Group: With more than 35 years of oncology experience and over 55 cancer centres worldwide, Icon delivers integrated cancer care, pioneering remote radiation planning and training, and the latest in radiotherapy technologies and techniques alongside clinical trials to expand access and improve results. 

Both organisations are part of the EQT global healthcare portfolio, sharing values of quality, partnerships, and a relentless focus on patient outcomes.  

This partnership is a logical step, strengthening Evidia’s position in oncology in Germany and further supporting Icon’s mission to deliver the best care possible, to as many people as possible, as close to home as possible.  

What this means for patients and communities

Patients and communities across Germany will benefit from enhanced value, quality, and services.  

The partnership places patients and clinicians at the heart of every decision, aiming to deliver measurable improvements in outcomes and access to care.  

Icon Group CEO, Mark Middleton OAM said this will benefit the region.    

“This partnership with Evidia brings together organisations that share our values of patient-centred care and quality as well as our ambition to deliver the best care possible, as close to home as possible,” said Mark.  

“Icon has a strong track record in partnerships and I’m confident this collaboration will demonstrate the power of shared knowledge and expertise and how together we can make a difference to more communities.”  

Looking ahead

This strategic partnership marks the beginning of a new era for oncology care in Germany.  

By combining diagnostics, therapy, and research, Evidia and Icon are committed to delivering integrated, patient-focused solutions that will shape the future of cancer treatment.